An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations
一项调整后的治疗比较研究:比较阿米万单抗与欧洲和美国真实世界临床实践在伴有表皮生长因子受体20号外显子插入突变的晚期非小细胞肺癌患者中的疗效
期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-022-02408-7
Chouaid, Christos; Bosquet, Lise; Girard, Nicolas; Kron, Anna; Scheffler, Matthias; Griesinger, Frank; Sebastian, Martin; Trigo, Jose; Viteri, Santiago; Knott, Craig; Rodrigues, Bernardo; Rahhali, Nora; Cabrieto, Jedelyn; Diels, Joris; Perualila, Nolen J; Schioppa, Claudio A; Sermon, Jan; Toueg, Raphael; Erdmann, Nicole; Mielke, Janka; Nematian-Samani, Mehregan; Martin-Fernandez, Cristina; Pfaira, Innocent; Li, Tracy; Mahadevia, Parthiv; Wolf, Jürgen